Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
DayTrading.com Publishes New Study Showing 70% Of Viral Finance TikToks Are Misleading
-
Nuburu Quarterly Strategic Update: Poised for Growth in Defense and Security
-
Viking Holdings Ltd Announces Launch of Senior Unsecured Notes Offering by Viking Cruises Ltd
-
New RLB Report Unites Cost and Activity Data, Reveals a Tale of Two Construction Markets
-
XXKK Exchange Launches App on Google Play, Bringing a Better Mobile Trading Experience
-
WaterBridge Announces Launch of $1,400,000,000 Offering of Senior Notes
-
Young America Capital Advises Cloud Carib in Strategic Growth Financing from Partners for Growth
-
WiMi's Lays out for the Research on Distributed Quantum Computing Based on Cross-Optical Network Links
-
DAR AL ARKAN PLANS TO LAUNCH "MANHATTAN" MASTERPLAN IN JEDDAH, A LANDMARK DESTINATION ON KING ABDULAZIZ ROAD FEATURING 'TRUMP PLAZA'
-
Beacon Global Strategies Announces Launch of International Trade Practice, Welcomes Sara Schuman as Managing Director
-
Beyond Meat Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $800 Million of Debt with Existing Noteholder Support
-
NATCOM: 14 Years Since Launching Telecom Services in Haiti
-
MacPaw Announces Jamf Marketplace Partnership and Strategic Leadership Appointments for CleanMyMac Business
-
Blazeo Launches Hybrid Voice AI, Blending Automation and Human Agents to Redefine Call Centers
-
The Truth Behind Egypt's Stolen Legacy: Livestream
-
D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex's Knee Osteoarthritis Program
-
dMY Squared Securities Expected to Begin Trading on OTC Markets on September 30, 2025
-
D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex's Knee Osteoarthritis Program
-
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
-
Novartis to Launch Direct-to-Patient Platform for Cosentyx® (secukinumab) in the US
-
MoonBull Presale Surges Past $142K at Stage 3 With 95% APY Staking and Smart Referral Program
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UNITE GROUP PLC/THE - Ordinary Shares
-
Preeminent SOL Treasury Company Helius (NASDAQ:HSDT) Announces Corporate Name Change to Solana Company and Letter of Intent with Solana Foundation
-
Maris-Tech Introduces Peridot Night: Advanced Thermal and Day Camera Solution for 360° Situational Awareness
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRENT COMMUNICATIONS PLC - Ordinary Shares
-
Wolfden Provides Drill Program Update at its Rockland Gold Project in the Walker Lane Trend of Nevada
-
Green Rain Energy Holdings Inc. (OTC:GREH) Enters Definitive Energy Purchase and Sales Agreement with Allied Energy Corporation to Accelerate EV Charging Corridor Rollout
-
Mosaic Consulting Expands Salesforce and Braze Services, Showcases Software Expertise with DrugAlert.ai
-
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
-
OULA PROVIDED BY STAMFORD HEALTH OPENS NEW MATERNITY CLINIC IN CONNECTICUT
-
Getty Images Announces Proposed Offering of Senior Secured Notes due 2030
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
LHH Executive Search Research Finds Nearly 60% of Leaders Plan to Change Roles Within the Next Three Years
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RICARDO PLC - Ordinary Shares
-
ATI Trade School Offers Solution To Trade School Instructor Shortage
-
Boehringer Ingelheim launches new direct-to-consumer platform to expand patient access to important treatments
-
DigiPayGuru Launches Merchant Acquiring Solution to Empower Banks & Fintechs with Seamless Payment Infrastructure
-
Novo Nordisk resubmits Awiqli® to the FDA with potential to be the first once-weekly basal insulin treatment for adults with type 2 diabetes
-
Vascarta Announces Completion of Phase 1 Clinical Trial of VAS-101 for the Treatment of Osteoarthritis
-
Atlanta Beltline Issues Request for Proposals for Transformative Development at 356 University Avenue
-
SecuGen Releases Unity 20 USB-S: A Versatile, Platform-Agnostic Fingerprint Reader for Developers
-
Gartner Says AI Vendor Race is Reshaping Competition Across the Entire AI Technology Stack
-
FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer
-
Agilysys Adds Hospitality Hall of Fame Member Sudharshan Chary To Its Executive Team
-
Quotient Therapeutics Appoints Drug Discovery and Development Veteran, Andrew Bayliffe, as Chief Development Officer
-
Zurich Honors SES Risk Solutions with Prestigious Pinnacle Award
-
Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
-
Silynxcom Lands $100,000 Order from Leading Military Unit for Advanced Tactical Communication Headsets
-
Parry Labs Works with US Marine Corps Demonstration to Explore New 'Colorless' Data Transfer Approaches
-
CeraVe and L'Oréal Groupe Win Prestigious IFSCC Applied Research Award for Breakthrough Dandruff Study
